Teva Pulls Version of Wellbutrin XL on Effectiveness

Teva Pharmaceutical Industries Ltd., the world’s largest generic-drug maker, pulled a copy of the antidepressant Wellbutrin XL from the U.S. market after regulators said it isn’t the same as the brand-name medicine.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.